Freestone Capital Holdings, LLC Astrazeneca PLC Transaction History
Freestone Capital Holdings, LLC
- $3.22 Billion
- Q3 2025
A detailed history of Freestone Capital Holdings, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 2,714 shares of AZN stock, worth $242,631. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,714Holding current value
$242,631% of portfolio
0.01%Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,510Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...